Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Trappenburg, A. van Deventer, S. van Vooren, J. Bourbeau, T. Troosters, G. Schrijvers, T. Verheij, J. W. Lammers, E. Monninkhof (Utrecht, Netherlands; , Canada; , Belgium). The impact of using different symptom-based exacerbation definitions in COPD patients. Eur Respir J 2010; 36: Suppl. 54, 4098

Member's Comments

No comment yet.

Related content which might interest you: COPD exacerbation definitions, assessment and diagnosis Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The effect of different tools in assessing the prevalence of depression in COPD patients Source: Annual Congress 2008 - Quality of life and mood disturbances in rehabilitation Year: 2008 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Validation of Anthonisen criteria in infectious COPD exacerbation among patients requiring hospitalization Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 The impact of COVID-19 on patients with asthma Source: Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020 Year: 2021 COPD exacerbations: definitions and classifications Source: Eur Respir J 2003; 21: 46S-53S Year: 2003 Comparison of functionality and symptoms in COPD patients with different nutritional status Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016